Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Sigma Aldrich Fine Chemicals Biosciences TranscreenerR ADP2 TR FRET

Supplier:  Sigma Aldrich Fine Chemicals Biosciences 3011

Encompass

The Transcreener(R) ADP2 TR-FRET Red Assay is a competitive immunoassay for ADP with a far-red time-resolved Foumlrster-resonance-energy-transfer (TR-FRET) readout. Because it is highly selective for ADP the assay can be used with any enzyme that converts ATP to ADP regardless of what other substrates are used. Examples of enzymes include protein lipid and carbohydrate kinases ATPases DNA helicases carboxylases and glutamine synthetase. The Transcreener(R) assay is designed specifically for high-throughput screening (HTS) with a single addition mix-and-read format. It offers reagent stability and compatibility with commonly used multimode plate readers. The generic nature of the Transcreener(R) HTS assay platform eliminates delays involved in assay development for new HTS targets and greatly simplifies compound and inhibitor profiling across multiple target families. The Transcreener(R) ADP2 TR-FRET Red Assay provides the following benefitsbullnbsp Accommodates ATP concentra

Catalog No. 50-290-6871


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.